Search results
Found 401 matches for
Study identifies biomarker for the diagnosis of Amyotrophic Lateral Sclerosis (ALS)
27 June 2018
Our Department collaborated with Oxford BioDynamics and Massachusetts General Hospital, Harvard Medical School.
Neurology features in BBC programme about the JR Hospital
21 June 2018
Aarti Jagannath presents the first in a new series about how the NHS changed our world
Oxford Centre for Neuroinflammation Launched
30 May 2018
We are delighted to announce the launch of the new Oxford Centre for Neuroinflammation (OCNI), which aims to shed light on the causes of neurodegenerative diseases and uncover new treatment pathways.
New Fellows of the Academy of Medical Sciences
10 May 2018
We are delighted to announce that David Beeson, Professor in Molecular Neurosciences, and Robert MacLaren, Professor of Ophthalmology, have been elected Fellows of the Academy of Medical Sciences.
Spot the difference
9 February 2018
Remember trying to spot the subtle differences between pictures as a child? It kept us quiet for hours! Neuroscientists including Chrystalina Antoniades have been working with staff at Oxford’s Ashmolean Museum on some interesting ‘spot the difference’ experiments, to try and find out more about how we perceive things.
Encephalitis Research Engagement Day
23 November 2017
On 14 November, NDCN's Autoimmune Neurology Group held an event for patients and public, to discuss the research on autoimmune encephalitis at the University of Oxford.
Trench Foot discovery paves way for new treatment
10 October 2017
A team including Professor David Bennett has uncovered the physical cause of trench foot more than 100 years after the painful and debilitating condition was first identified in the First World War.
Potential new route to treatment for Cerebellar Ataxia?
18 September 2017
Researchers from the teams of Andrea Németh (NDCN) and Esther Becker (DPAG) have published an important paper reporting dominant mutations that cause a new type of cerebellar ataxia, Spinocerebellar Ataxia type 44.
James Parkinson 200th anniversary events
14 September 2017
This year marks the 200th anniversary of the publication of the first codified description of the condition that we now know as Parkinson's disease.
New consortium to investigate Alzheimer’s and Parkinson’s diseases
10 April 2017
New research project could enable novel therapeutic approaches in Alzheimer’s and Parkinson’s diseases.
Cannabinoid biomedicine research programme launched
17 March 2017
Oxford University and Kingsley Capital Partners have launched a new research programme to investigate the role of cannabinoids in biology and medicine.
New Oxford Neurodevelopment Consortium
13 January 2017
Professor Andrea Németh has successfully applied to the John Fell Fund to establish the Oxford Neurodevelopment Consortium (OxNDC).
New drug trial for Parkinson's
12 December 2016
Our researchers have been granted 600K euros from EU’s Horizon 2020 Framework Programme to join in a multi-centre initiative studying a new drug for Parkinson's disease
Brain activity predicts the force of your actions
24 November 2016
A clear link between the activity in nerve clusters in the brain and the amount of force generated in a physical action has been demonstrated by our researchers, opening the way for the development of better devices to assist paralysed patients.